Unknown OBSERVATIONAL NCT05176704

Development and Validation of a Novel Functional Eye-Tracking Software Application for Alzheimer's Disease

Sponsor: Innodem Neurosciences

Updated 11 times since 2022 Last updated: Feb 12, 2024 Started: Apr 15, 2022 Primary completion: Mar 3, 2024 Completion: Mar 3, 2024

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This observational or N/A phase trial investigates Alzheimer's Disease and is currently ongoing. Innodem Neurosciences leads this study, which shows 11 recorded versions since 2022 — indicating substantial longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Status Flow

Change History

11 versions recorded

Mar 2026 — Present [monthly]

Unknown

Status: Recruiting → Unknown
Sep 2025 — Mar 2026 [monthly]

Recruiting
Sep 2024 — Sep 2025 [monthly]

Recruiting
Jul 2024 — Sep 2024 [monthly]

Recruiting
Mar 2024 — Jul 2024 [monthly]

Recruiting

▶ Show 6 earlier versions

Nov 2023 — Mar 2024 [monthly]

Recruiting
Sep 2022 — Nov 2023 [monthly]

Recruiting
Jun 2022 — Sep 2022 [monthly]

Recruiting
May 2022 — Jun 2022 [monthly]

Recruiting

Status: Not Yet Recruiting → Recruiting
Mar 2022 — May 2022 [monthly]

Not Yet Recruiting
Jan 2022 — Mar 2022 [monthly]

Not Yet Recruiting

First recorded

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Innodem Neurosciences

Data source: Innodem Neurosciences

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Montreal, Canada